fermer

Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis.

Campos N, Myburgh R, Garcel A, Vautrin A, Lapasset L, Nadal ES, Mahuteau-Betzer F, Najman R, Fornarelli P, Tantale K, Basyuk E, Séveno M, Venables JP, Pau B, Bertrand E, Wainberg MA, Speck RF, Scherrer D, Tazi J

Retrovirology.

2015 Apr 9 / vol 12 / pages 30

Toutes les publications